Elevance Health (ELV) Invested Capital (2009 - 2026)

Elevance Health (ELV) has 18 years of Invested Capital data on file, last reported at $724.0 million in Q1 2026.

• On a quarterly basis, Invested Capital rose 189.6% year-over-year to $724.0 million in Q1 2026; TTM through Jun 2026 was $1.1 billion, a 65.72% decrease from a year earlier, with the FY2025 full-year figure at $150.0 million, down 58.9% from the prior year.
• Invested Capital for Q1 2026 stood at $724.0 million, up from $150.0 million in the prior quarter.
• Over the last five years, Invested Capital for ELV reached as high as $3.1 billion in Q1 2022 and fell as low as $150.0 million in Q4 2025.
• Historically, Invested Capital has averaged $1.1 billion across 5 years, with a median of $365.0 million in 2024.
• Across the five-year window, Invested Capital jumped 1184.57% in 2022 and slumped 91.44% in 2023, its largest moves.
• Year by year, Invested Capital stood at $265.0 million in 2022, then fell by 15.09% to $225.0 million in 2023, then jumped by 62.22% to $365.0 million in 2024, then tumbled by 58.9% to $150.0 million in 2025, then surged by 382.67% to $724.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $724.0 million in Q1 2026, $150.0 million in Q4 2025, and $180.0 million in Q3 2025.